December 29, 2014 5:33 AM ET

Biotechnology

Company Overview of Theraclone Sciences, Inc.

Company Overview

Theraclone Sciences, Inc., a discovery-stage biopharmaceutical company, engages in the discovery and development of monoclonal antibody therapeutics for the treatment of infectious diseases and inflammation. The company focuses on identifying rare fully human antibodies from immunologically relevant human subjects by using its proprietary antibody discovery technology, I-STAR (In-Situ Therapeutic Antibody Rescue). It has a portfolio of antibody programs at preclinical and clinical development stage targeting various medical conditions, including influenza, HIV, other bacterial targets, breast cancer, and infectious disease-associated cancers. Theraclone Sciences, Inc. has strategic collabora...

1124 Columbia Street

Seattle Life Sciences Building

Suite 300

Seattle, WA 98104

United States

Founded in 2004

Phone:

206-805-1600

Fax:

206-805-1699

Key Executives for Theraclone Sciences, Inc.

Chief Executive Officer and Director
Age: 55
Founder and Member of Scientific Advisory Board
Chief Financial Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Theraclone Sciences, Inc. Key Developments

Theraclone Sciences Announces Licenses Agreement with Gilead Sciences

Theraclone Sciences, Inc. has entered into a license agreement with Gilead Sciences, Inc. to develop and commercialize products incorporating Theraclone's broadly neutralizing human immunodeficiency virus (HIV)-antibodies for therapeutic applications in HIV. Both the companies are based in the US. Under the terms of the transaction, Theraclone will receive an upfront payment and is eligible to receive additional payments based upon achievement of certain development and commercialization milestones.

Theraclone Sciences, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-20-2014 10:00 AM

Theraclone Sciences, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-20-2014 10:00 AM. Venue: Washington State Convention Center, Seattle, Washington, United States.

Theraclone Sciences, Inc. Presents at Boston CEO Conference, Jun-05-2014 09:00 AM

Theraclone Sciences, Inc. Presents at Boston CEO Conference, Jun-05-2014 09:00 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Clifford J. Stocks, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
Asuragen, Inc. United States
Hepregen Corporation United States
Jackson ImmunoResearch Laboratories, Inc. United States
Solstice Biologics LLC United States
Metaclipse Therapeutics Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Theraclone Sciences, Inc., please visit www.theraclone-sciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.